BNTX

BioNTech Share Price

294.6033
12.64 (4.48%)
Upgrade to Real-Time
Regular Market
294.6033
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
BioNTech SE BNTX NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
12.64 4.48% 294.6033 10:18:21
Open Price Low Price High Price Close Price Prev Close
289.50 288.2338 297.7299 281.96
Bid Price Ask Price Spread News
294.30 294.64 0.34 - 3
Trades Volume VWAP Dollar Volume Avg Volume
20,650 1,333,251  291.30  388,374,030 -
Last Trade Time Type Quantity Stock Price Currency
10:18:21 1  294.435 USD

Period:

Draw Mode:

BioNTech SE Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
 71.15B 241.52M 241.52M  584.89M  305.37M 0.07 49.50
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
-  - - - -

more financials information »

News BioNTech

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

BNTX Historical

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.0%
1 Month0.000.000.000.0000.000.0%
3 Months0.000.000.000.0000.000.0%
6 Months0.000.000.000.0000.000.0%
1 Year0.000.000.000.0000.000.0%
3 Years0.000.000.000.0000.000.0%
5 Years0.000.000.000.0000.000.0%

BioNTech SE is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and small-molecule immunomodulators. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Comirnaty (COVID-19 vaccine) is its first commercialized product.


Your Recent History
NASDAQ
BNTX
BioNTech
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.